Wealthspire Advisors, LLC Bristol Myers Squibb CO Transaction History

Wealthspire Advisors, LLC

$7.78 Billion
Q2 2024

A detailed history of Wealthspire Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Wealthspire Advisors, LLC holds 27,223 shares of BMY stock, worth $1.45 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

27,223

Previous 28,687 5.1%

Holding current value

$1.45 Million

Previous $1.56 Million 27.33%

% of portfolio

0.01%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$40.25 - $52.99 $58,926 - $77,577	-1,464 Reduced 5.1%	27,223 $1.13 Million
Q1 2024 May 06, 2024	SELL	$47.98 - $54.4 $322,137 - $365,241	-6,714 Reduced 18.97%	28,687 $1.56 Million
Q4 2023 Feb 06, 2024	BUY	$48.48 - $57.85 $289,037 - $344,901	5,962 Added 20.25%	35,401 $1.82 Million
Q3 2023 Nov 06, 2023	BUY	$57.89 - $64.73 $282,387 - $315,752	4,878 Added 19.86%	29,439 $1.71 Million
Q2 2023 Jul 31, 2023	SELL	$63.71 - $70.74 $160,676 - $178,406	-2,522 Reduced 9.31%	24,561 $1.57 Million
Q1 2023 May 09, 2023	SELL	$65.71 - $74.53 $288,992 - $327,782	-4,398 Reduced 13.97%	27,083 $1.88 Million
Q4 2022 Feb 13, 2023	BUY	$68.48 - $81.09 $247,966 - $293,626	3,621 Added 13.0%	31,481 $2.26 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $665 - $393,651	5,123 Added 22.53%	27,860 $1.98 Million
Q2 2022 Aug 09, 2022	BUY	$72.62 - $79.98 $350,972 - $386,543	4,833 Added 26.99%	22,737 $1.75 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $372,999 - $447,259	-6,067 Reduced 25.31%	17,904 $1.31 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $94,656 - $110,347	1,765 Added 7.95%	23,971 $1.5 Million
Q3 2021 Nov 15, 2021	BUY	$59.17 - $69.31 $955,713 - $1.12 Million	16,152 Added 266.8%	22,206 $1.31 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $2.12 Million - $2.31 Million	-34,236 Reduced 84.97%	6,054 $405,000
Q1 2021 May 17, 2021	BUY	$59.34 - $66.74 $516,258 - $580,638	8,700 Added 27.54%	40,290 $2.54 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $582,538 - $660,123	10,089 Added 46.92%	31,590 $1.96 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $207,379 - $229,804	3,611 Added 20.18%	21,501 $1.3 Million
Q2 2020 Aug 14, 2020	SELL	$54.82 - $64.09 $1.01 Million - $1.19 Million	-18,515 Reduced 50.86%	17,890 $1.05 Million
Q1 2020 May 12, 2020	BUY	$46.4 - $67.43 $1.26 Million - $1.83 Million	27,128 Added 292.42%	36,405 $2.03 Million
Q4 2019 Feb 14, 2020	BUY	$49.21 - $64.19 $214,555 - $279,868	4,360 Added 88.67%	9,277 $595,000
Q3 2019 Nov 12, 2019	BUY	$42.77 - $50.71 $210,300 - $249,341	4,917 New	4,917 $249,000
Q1 2019 May 08, 2019	SELL	$45.12 - $53.8 $48,007 - $57,243	-1,064 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $51,880 - $67,276	1,064 New	1,064 $55,000

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealthspire Advisors, LLC with notifications on news.

Account

Wealthspire Advisors, LLC Bristol Myers Squibb CO Transaction History